OVERVIEW

4th Annual LNP Characterization & Analytical Development Summit is organized by Hanson Wade and will be held from Nov 18 - 19, 2026 at The Colonnade Hotel, Boston, Massachusetts, United States of America.

Description:
As LNP systems become more sophisticated and RNA therapeutics move toward targeted delivery, multi-cargo constructs, and increasingly complex modalities, the demands on characterization and analytical development have never been greater. Traditional approaches are no longer sufficient to define product quality, understand structure-function relationships, or meet evolving regulatory expectations.

Join analytical development, characterization, formulation, and CMC leaders from across pharma and biotech to uncover the latest advances in predictive CQAs, structural characterization, targeted LNP analytics, multi-attribute methods, and strategies for complex payload systems. Through technical case studies, interactive discussions, poster presentations, and high-value networking, gain practical insight into how the industry is accelerating development while reducing risk.

As innovation in RNA medicines continues to outpace analytical standards, this is the critical meeting point to benchmark approaches, shape future best practice, and stay ahead of the next generation of LNP development.

KEY DATES

Registrations Open
01 Aug, 2026
Registrations Open
Event Start Date
18 Nov, 2026
Event Start Date
Event End Date
19 Nov, 2026
Event End Date

TARGET AUDIENCE

PharmacistPharmaceuticalsClinical Pharmacology

SPECIALITIES

PharmacologyPharmacy and MedicineBiotechnology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationThe Colonnade Hotel
120 Huntington Avenue

RELATED CONFERENCES & LIVE WEBINARS